Pubblicazioni

Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia  (2010)

Autori:
DELLA PERUTA, Marco; Martinelli, M.; Moratti, E.; Pintani, D.; Vezzalini, Marzia; Mafficini, Andrea; Grafone, T.; Iacobucci, I.; Soverini, S.; Murineddu, M.; Vinante, Fabrizio; Tecchio, Cristina; Piras, G.; Gabbas, A.; Monne, M.; Sorio, Claudio
Titolo:
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia
Anno:
2010
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
A Stampa
Referee:
Nome rivista:
Cancer Research
ISSN Rivista:
0008-5472
N° Volume:
70
Numero o Fascicolo:
21
Intervallo pagine:
8896-8906
Parole chiave:
Chronic myeloid leukemia; tyrosine phosphatase; tumor suppressor gene; biomarker
Breve descrizione dei contenuti:
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine phosphatase receptor type γ (PTPRG) is a tumor suppressor gene and a myeloid cell marker expressed by CD34+ cells. Downregulation of PTPRG increases colony formation in the PTPRG-positive megakaryocytic cell lines MEG-01 and LAMA-84 but has no effect in the PTPRG-negative cell lines K562 and KYO-1. Its overexpression has an oncosuppressive effect in all these cell lines and is associated with myeloid differentiation and inhibition of BCR/ABL-dependent signaling. The intracellular domain of PTPRG directly interacts with BCR/ABL and CRKL, but not with signal transducers and activators of transcription 5. PTPRG is downregulated at the mRNA and protein levels in leukocytes of CML patients in both peripheral blood and bone marrow, including CD34+ cells, and is reexpressed following molecular remission of disease. Reexpression was associated to a loss of methylation of a CpG island of PTPRG promoter occurring in 55% of the patients analyzed. In K562 cell line, the DNA hypomethylating agent 5-aza-2′-deoxycytidine induced PTPRG expression and caused an inhibition of colony formation, partially reverted by downregulation of PTPRG expression. These findings establish, for the first time, PTPRG as a tumor suppressor gene involved in the pathogenesis of CML, suggesting its use as a potential diagnostic and therapeutic target.
Id prodotto:
57750
Handle IRIS:
11562/345316
depositato il:
21 marzo 2012
ultima modifica:
15 novembre 2022
Citazione bibliografica:
DELLA PERUTA, Marco; Martinelli, M.; Moratti, E.; Pintani, D.; Vezzalini, Marzia; Mafficini, Andrea; Grafone, T.; Iacobucci, I.; Soverini, S.; Murineddu, M.; Vinante, Fabrizio; Tecchio, Cristina; Piras, G.; Gabbas, A.; Monne, M.; Sorio, Claudio, Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia «Cancer Research» , vol. 70 , n. 212010pp. 8896-8906

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

Progetti Collegati
Titolo Dipartimento Responsabili
PTPRG as a novel tumor suppressor gene in chronic myeloid leukemia and its clinical implications Dipartimento Ingegneria per la medicina di innovazione Claudio Sorio
<<indietro

Attività

Strutture

Condividi